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Background: MicroRNAs (miRNAs) have been recognized as one of the key regulatory non-coding RNAs that are
involved in a number of basic cellular processes. miRNA expression profiling helps to identify miRNAs that could
serve as biomarkers. Next generation sequencing (NGS) platforms provide the most effective way of miRNA
profiling, particularly as expression of different isoforms of miRNA (IsomiRs) can be estimated by NGS. Therefore, it is
now possible to discern the overall complexity of miRNA populations that participate in gene regulatory networks.
It is thus important to consider different isoforms of miRNA as part of total profiling in order to understand all
aspects of the biology of miRNAs.
Results: Here next generation sequencing data of small RNAs derived from normal peripheral blood mononuclear
cells (PBMC) and Chronic myeloid leukemia (CML) patients has been used to generate miRNA profiles using a
computation pipeline which can identify isomiRs that are natural variants of mature miRNAs. IsomiR profiles have
been generated for all the 5p and 3p miRNAs (previously known as major mature miRNA and minor or miRNA*)
and the data has been presented as a composite total miRNA transcriptome. The results indicated that the most
abundant isomiR sequence of about 68% miRNAs, did not match the reference miRNA sequence as entered in the
miRBase and that there is a definite pattern in relative concentration of different isomiRs derived from same
precursors. Finally, a total of 17 potential novel miRNA sequences were identified suggesting that there are still
some new miRNAs yet to be discovered.
Conclusions: Inclusion of different isoforms provides a detailed miRnome of a cell type or tissues. Availability of
miRnome will be useful for finding biomarkers of different cell types and disease states. Our results also indicate
that the relative expression levels of different isoforms of a miRNA are likely to be dynamic and may change with
respect to changes in the cell or differentiation status.
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MicroRNAs (miRNA) are a major class of small non-
coding RNAs of about 22 nucleotides that are involved
in various cellular functions. miRNAs are transcribed as
pri-miRNAs which are processed into pre-miRNAs by
an RNase III enzyme, Drosha. Pre-miRNAs are exported
to cytoplasm and processed by another RNAse III en-
zyme, Dicer to give rise to mature miRNAs. These two
enzymes are important not only for processing of inter-
mediates to mature miRNAs but also for introducing
variations in miRNAs [1-3].
Several reports have established miRNAs as important
post transcriptional regulators of gene expression
through different mechanisms, such as translational re-
pression and destabilization and cleavage of the target
mRNA. The processes are initiated by binding of the
miRNA to partially complementary sites at the 3′UTR
of the target mRNA in animals and completely comple-
mentary sites in plants [4,5]. A single miRNA can bind
to several target mRNAs and similarly a multitude of
them can bind a single target [6]. Recent estimates sug-
gest that a substantial fraction (up to 60%) of higher
eukaryotic mRNAs is regulated by these small non cod-
ing RNAs [7]. Therefore, miRNAs and mRNAs are part
of intricate networks that regulate gene expression and
cellular decision making [8,9]. The existence of miRNA
clusters and families also add to the intricacies of
miRNA regulation [10]. In order to understand these
networks, knowledge of complete miRNA expression
profiles is necessary. Expression profiles can also be
helpful in identifying tissue, stage and disease-specific
patterns. miRNAs have also been shown to be involved
in cancer and tumorigenesis [11-13]. It is generally be-
lieved that some of the miRNAs can be useful diagnostic
and prognostic markers of different cancers with appli-
cations in patient care and therapy [14].
A number of approaches, such as northern blotting,
RNase protection assay, PCR, microarrays and RAKE
assay have been used for expression profiling of miRNAs
[15-20]. In general these methods are either cumber-
some for scaling up and/or not sensitive enough to de-
tect low levels. miRNAs are expressed at different levels,
spanning more than five orders of magnitude and major-
ity of methods are not suitable to get accurate expres-
sion profiles. Microarrays have problems associated with
cross hybridization and creating a single hybridization
condition suitable for all miRNAs [20]. Most of these
methods could detect only pre-miRNAs owing to the
technical difficulty caused by short length of mature-
miRNAs. Next generation sequencing (NGS) has pro-
vided an edge over other methods in generating, not just
an in depth knowledge of known miRNA expression,
but also helped in identifying tissue-specific, and rarely
expressed miRNAs [21-25]. NGS approach has also beensuccessful in new miRNA discovery leading to exponen-
tial increase in miRBase entries in the last few years
(Release 19) [26,27]. Moreover, analysis of small RNA
(sRNA) sequencing data derived using NGS platforms
has helped to identify alternate processing products of
biogenesis. It is clear from some of the preliminary ana-
lysis that these alternate processing products are bio-
logically relevant and can have functional role probably
by binding different Argonaute proteins [24,25,28,29].
The previously known as minor or “miR*” sequences
were found to be expressed higher than the major coun-
terparts raising the need for a change in the annotation.
Therefore, the annotation of miRNAs as-5p/-3p rather
than mature and star is now used by the latest miRBase
Release 19.
In this report, a detailed analysis on human PBMC
miRnome has been described. Our analysis involves dif-
ferent processing products that include isomiRs of both
miR-5p and miR-3p thus forming a composite miRNA
transcriptome. We have generated the reference miRNA
profile comprising of the miRNAs in miRBase as well as
the abundant isomiR profile using our NGS data. On
comparing the reference miRNA and the abundant
isomiR profiles we found that the abundant isomiRs dif-
fer in different cells suggesting that miRNA profiling
must include all the variants for developing biological
markers in different diseases.
A few potential novel miRNAs have also been detected
during our analysis [30]. Our report highlights intricacies
in miRNA biogenesis machinery that can be used as a
signature of physiological state of cells.
Results
Annotation and apportionment
sRNA datasets comprising of two Normal PBMCs and
two CML patients were pre-processed as described in
“Methods” and the distribution of the length of the reads
was plotted to determine the optimal read length cut-off
(Figure 1). Both the Normal samples displayed a normal
distribution with the peak at 22nt (average length of ma-
ture miRNAs). In contrast, 17nt was found to be the
most frequent size of small RNAs in Patient samples in-
dicating higher amount of degradation in these samples.
The read length of 14nt was taken as the cut-off length.
Therefore reads having lengths greater than 14nt were
used for the analysis. The basic statistics about these dif-
ferent datasets is shown in Table 1. The sequences were
then analyzed using a computational pipeline that has
been described and briefly mentioned in “Methods” in
order to classify sequences into different known RNA
categories, such as miRNA, sn/sno RNAs, lincRNAs,
tRNAs, rRNAs and mRNAs [24]. The reads, that could
not be classified (unannotated ones), were further
mapped to the intergenic and intronic regions of the
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Figure 1 Analysis of lengths of the reads from the four samples to determine the optimal cut-off read length. A. Frequency distribution
of lengths of the reads from the two Normal samples. B. Frequency distribution of lengths of the reads from the two Patient samples.
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and used for novel miRNA prediction [30-32].
Results from the annotation pipeline (Figure 2) showed
that miRNAs were the most abundant small RNA species
[74% in Normal1, 73% in Normal2, 54% in Patient1 and
62% in Patient2]. Overall the total fraction of miRNAs in
the population was relatively less in the Patient samples as
compared to that of the Normal samples. The reads de-
rived from other non-coding sRNAs, such as sn/sno
RNAs, lincRNAs and miscellaneous RNAs were 1–3%,
1–6% and 1–5% respectively. The reads derived from lar-
ger RNA categories, such as the tRNAs were 2–6% andTable 1 Details of the samples
Sample Total number of reads
Normal1 11,518,605
Normal2 10,878,898
Patient1 10,701,151
Patient2 11,512,769the rRNAs were about 1%. The mRNAs were around
3–5% in the Normals suggesting that degradation was
minimal in the Normal samples. However the fraction of
mRNAs were slightly higher in Patient samples (8–14%)
indicating more degradation in the Patient samples due to
cell death and necrosis. This is also evident from the
length distribution of the reads (Figure 1).
Reads that matched to the human genome but not
with any known RNA species (unannotated reads) were
5–7%. These were taken for novel miRNA prediction.
Lastly, the total unmatched pool that failed to match
with the human genome was around 7–9% (Figure 2).Total number of reads (> = 14nt)
11,490,402
10,855,039
10,637,119
11,477,587
Figure 2 Distribution of different classes of RNAs present in the four samples. The pie-charts represent an overview of the small RNAs in
the Normal and Patient samples. The miRNAs constitute a major portion of all the four samples; the Normals display a higher proportion of
miRNAs as compared to the Patient samples.
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In general, the stem part of the precursor sequences is
processed with Dicer enzyme to give rise to mature
miRNAs. Previously, one of the arms was considered to
form the mature miRNA whereas the other formed the
minor or the star sequence. The expression levels deter-
mined the major/minor nomenclature. Recently, several
reports have shown that this nomenclature could vary
with the tissue and experimental conditions causing the
change in the nomenclature. These are now referred to
as miR-5p and miR-3p depending on their location in
the precursor sequence. The miRBase [26,27] is a reposi-
tory of miRNAs, and the mature form of miRNAs in
miRBase is referred here as the reference miRNAs. Theexpression profiles of these reference miRNAs were
obtained by identifying the reads from our NGS samples
that showed an exact match with them.
The expression profile of these reference miRNAs was
called the Reference miRNA expression profile (Additional
file 1). Furthermore, the similarity and the differences
between the samples and within each group, was deter-
mined using the Reference miRNA expression profile.
The Hierarchical clustering plot computed using the
Reference miRNA expression profile, showed that the
Normal1 and Normal2 samples were closer to each
other forming one group. Similarly, the Patient1 and
Patient2 samples were closer to each other forming an-
other group (Figure 3).
Figure 3 Hierarchical clustering plot showing the similarity and
differences between the samples. The Normal samples (1 and 2)
and the Patient samples (1 and 2) cluster into two separate groups.
The plot shows the proximity of the two Normals and the two
Patients to each other, and the distance between the Normal group
and the Patient group on the whole. Clustering plots were
generated using both: the Reference miRNAs expression profile and
the Abundant IsomiR expression profile.
Table 2 Comparison of the reference and abundant
IsomiR expression profiles
Comparison details Normal
samples
Patient
samples
Reference miRNAs that matched the most
abundant isomiRs (YES cases)
204 190
Reference miRNAs that did not match most
abundant isomiRs (NO cases)
404 429
MiRNAs not considered 1434 1423
Comparison of the two expression profiles in Normal and Patient samples.
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miRNAs are also known to have alternative forms called
“isomiRs”, that differ from each other by a few nucleo-
tides at the ends. These are thought to be generated by
alternate Dicer cutting [23]. Identification of isomiR
family has been discussed in the “Methods” section.
Briefly, sequencing reads of each sample were aligned to
the human pre-miRNAs to obtain an isomiR family for
each mature miRNA (−5p/−3p). The Additional file 2
shows an example of a hsa-let-7b isomiR family with
their respective frequency or expression values. Quite
often only one of these isomiRs displays dominant ex-
pression, that is, has highest number of reads among all
the other isomiRs. This dominant isomiR is considered
to be the active or mature form of miRNAs.
We generated the isomiR expression profiles of all
miRNAs and determined the dominant isomiR for each
expressed miRNA based on the highest frequency. The
Additional file 3 lists the most abundant isomiR for
every expressed mature miRNA (Abundant isomiR ex-
pression profile).
The clustering of the samples was once again checked
using the Abundant IsomiR expression profile. The
Hierarchical clustering plot computed using the Abun-
dant IsomiR expression profile gave results similar to
that obtained using the Reference miRNA expression
profile. The Normal1 and Normal2 samples were closer
to each other forming one group. Similarly, Patient1 and
Patient2 samples were closer to each other forming an-
other group (Figure 3).We then answered the question whether the most
abundant isomiR was the same as the reference miRNA
by comparing the Reference and the Abundant isomiR
expression profiles. If the most abundant isoform of a
miRNA was not the reference miRNA, it was reported
as “NO”, whereas if the abundant one matched the refer-
ence miRNA it was reported as “YES”. The Additional
file 4 lists this comparison.
Analysis of the “YES” or “NO” data revealed some inter-
esting facts (Table 2). We focused on a total of 608
miRNAs that were expressed in both the Normal samples
and displayed uniformity in being either YES/NO among
them. For the rest of 1434 miRNAs in Normals either the
expression levels were low, below the detection limit (1289)
or were non uniform (145). Out of 608 miRNAs analyzed,
the reference miRNA sequence of only 204 miRNAs
matched with the most abundant isomiR (YES cases), while
for 404 miRNAs, the reference sequence did not match the
most abundant isomiR (NO cases) (Table 2).
The same was seen for the patients; around 619 miRNAs
were expressed and displayed uniformity in being YES/NO
among both the Patient samples. The remaining 1423
miRNAs had either a low expression (1293) or were non
uniform (130). Out of the 619 miRNAs analysed, the refer-
ence miRNA sequences of only 190 miRNAs matched with
the most abundant isomiR (YES cases), while for 429
miRNAs, the reference sequence did not match the most
abundant isomiR (NO cases) (Table 2).
The latter category (NO category) included some of
the miRNAs that are known to be involved in cancer
biology, such as let-7b-3p, let-7d-5p, let-7 g-3p, 10a-5p,
15b-5p, 16-1-3p, 16-2-3p, 21-5p, 21-3p, 23a-3p, 23b-3p,
26b-5p, 26b-3p, 30d-5p. A few examples of such
miRNAs for the Normals and Patients are shown in
Table 3A,B respectively. Therefore a mature miRNA is
not always the same sequence or isoform and appears to
vary though the precursor sequence remains the same.
Expression profile comparison
Reference miRNA expression profile
Expression of 620 miRNAs (on an average) including
about 70–90 singletons were observed in each sample.
The level of expression of the miRNAs was found to be
Table 3 Few examples revealing differences in the expression profiles based on selection of the most abundant isomiR
versus the reference miRNA
3A)
miRNAs
Normal 1 Normal 2
Reference miRNA
frequency
Most abundant isomiR
frequency
Reference miRNA
frequency
Most abundant isomiR
frequency
hsa-miR-10a-5p 171 935 195 792
hsa-miR-15b-5p 2266 4355 992 2547
hsa-miR-21-5p 30955 49979 33091 50565
hsa-miR-23a-3p 11160 21009 8375 17718
hsa-miR-26b-5p 3409 28934 3685 23018
hsa-miR-30d-5p 1449 14156 1893 15233
3B)
miRNAs
Patient 1 Patient 2
Reference miRNA
frequency
Most abundant isomiR
frequency
Reference miRNA
frequency
Most abundant isomiR
frequency
hsa-miR-10a-5p 56 256 99 396
hsa-miR-15b-5p 1835 2342 1187 4114
hsa-miR-21-5p 8868 18032 36712 75907
hsa-miR-23a-3p 5793 11774 8296 16159
hsa-miR-26b-5p 2239 12346 10093 51801
hsa-miR-30d-5p 1638 8012 1619 15705
A) in Normal samples. (B) in Patient samples.
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values spanning five orders of magnitude in Normals
(Figure 4A) and Patients (Figure 4B). The highly
expressed miRNAs (>10,000 frequency count) detected
by using this profile were the let-7 family followed by hsa-
miR-103a-3p, 148a-3p, 16-5p, 185-5p, 191-5p, 192-5p,
223-3p, 24-3p, 25-3p, 26a-5p, 29a-3p, 3184-3p, 320a, 423-
5p and 92a-3p similar to what has been seen before [24].
Abundant IsomiR expression profile
On an average about 875 miRNAs including about
20–55 singletons were expressed in each sample.
Around 255 more miRNAs were found using this abun-
dant isomiR profile that was missed out in the Reference
miRNA profile owing to the absence of the reference se-
quence for these miRNAs.
The level of expression of the miRNAs was found to be
variable just like the reference miRNA (Additional file 3)
profiles but of a higher level owing to more number of
miRNAs detected by using this profile in Normals
(Figure 4A) and Patients (Figure 4B). On using this profile
we got a bigger list of highly expressed miRNAs (>10,000
frequency count). This included miRNAs found to be
highly expressed using the reference miRNA profile as
well as comprised of a few more miRNAs that failed to be
picked out as highly expressed on using the reference
miRNA profile owing to the presence of another isomiR
sequence that had a higher frequency than the referencesequence. Some of these miRNAs were: hsa-miR-107,
140-3p, 21-5p, 23a-3p, 26b-5p, 3074-5p, 378a-3p.
Interestingly, highly expressed miRNAs display more
isomiRs as compared to those miRNAs that are expressed
at a lower level. Figure 5 shows the distribution of number
of IsomiRs of a few selected highly expressed miRNAs
among the four samples. The distribution patterns appeared
to be similar among the four samples. Number of isomiRs
of hsa-let-7a-5p was found to be highest followed by hsa-
mir-185-5p, hsa-mir-16-5p, hsa-mir-148a-3p, hsa-mir-103a-
3p (in descending order).
Novel miRNA identification
The reads that did not match with the annotated se-
quence databases and that mapped to intergenic and in-
tronic regions of the human genome were checked to
see if these were potential novel miRNAs. In this case
only exact matches were considered for further analysis
by extracting the matched region along with 70 nucleo-
tides flanking on either side. The extracted sequences
were folded and checked by prediction algorithms, such
as CID-miRNA [31], CSHMM [32], miRDeep [33] and
MiPred [34] for potential pre-miRNAs. The predictions
were further analyzed using a set of filters for false posi-
tives as described before [24]. This analysis led to detec-
tion of 17 potential novel miRNAs which have been
given unique names with the prefix “jnu-pat-hsa”. The
sequence and the structures of two potential novel
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Figure 4 Analysis of the expression patterns of the reference miRNAs and the most abundant IsomiRs. A. The distribution of the
reference (Ref) and the most abundant (Abund) miRNA levels with respect to number of miRNAs for Normal 1 and 2. B. The distribution of the
reference (Ref) and the most abundant (Abund) miRNA levels with respect to number of miRNAs for Patient 1 and 2. Numbers of sequence reads
are taken as miRNA levels and the values are represented in the form of range of values. The expression levels of the miRNAs span up to five
orders of magnitude.
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potential novel miRNAs, including their frequencies,
isomiRs, prediction scores from the tools, the sequences
of precursor and mature forms are given in Additional
file 5. The structures of the precursors are given in
Additional file 6.
Discussion and conclusions
The major goal of this study was to understand the
complete miRNA transcriptome in the context of hu-
man PBMCs obtained using deep sequencing of small
RNA through custom designed computational tools. The
expression of the reference mature miRNAs is com-
monly considered to form the miRNA transcriptome.Since NGS allows identification of isomiRs of miR-5p
and miR-3p, it is important to include these processing
variants as part of the complete miRNA transcriptome
[23,27,28]. In our previous study we had profiled
miRNAs in Normal PBMC and in CML cell line K562
and identified a number of differentially expressed
miRNAs [24]. The study did not include human patient
cells and isomiR profiling.
The presence of isomiRs was first reported by Morin
et.al. 2008 based on their analysis of miRNA sequences
obtained through deep sequencing of human embryonic
stem cells [23]. These miRNA variants or the IsomiRs
have variable 5′ and 3′ extensions. The miRNA tran-
scriptome consists of sum total of different isomiR
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Figure 5 Distribution of isomiRs in a group of highly expressed miRNAs. The selected highly expressed miRNAs are hsa-let-7a-5p,
hsa-mir-103a-3p, hsa-mir-148a-3p, hsa-mir-16-5p, hsa-mir-185-5p and the patterns appear to be similar across the four samples.
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methods of miRNA profiling, sRNA sequencing using
NGS platforms is capable of identifying all these vari-
ants. Some recent studies have reported tissue specific
accumulation of miRNAs and their counterpart se-
quences. Preferential expression of IsomiRs has also
been reported in tissue specific manner [35]. Profiling of
miRNAs in different lymphoid cells has been carried
out. For example, one study reported a comprehensive
profiling of miRNAs and their isomiRs expressed in B-
cells from Jewish centenarians [36]. There is a manually
curated database of extracellular circulating miRNAs
called the miRandola which is connected to the miRNA
knowledge base, making it useful for inferring the poten-
tial biological functions of circulating miRNAs [37].Figure 6 Sequence and structure of two potential novel miRNAs. The
such as CID-miRNA, CSHMM, miRDeep and MiPred. These are two exampleWe have used this extended definition of miRNA tran-
scriptome to study the total miRNA transcriptome of
Normal PBMCs and CML patients. Since this was a pilot
study comprising of two Normal PBMC and two CML
patient samples, no attempt was made to identify differ-
entially expressed miRNA isoforms among the normal
and patient samples. In general, distribution of miRNA
isoforms in normal and patient tissues displayed similar
patterns (Additional files 1, 2, 3, 4).
Our results show that mature miRNAs have to be de-
fined with respect to a specific cell type, as relative levels
of different isoforms are dynamic in nature. Therefore,
we have taken into consideration different isomiRs and
looked for the most abundant isomiR and compared
with the reference miRNAs (as in miRBase). Our resultspotential precursors were folded and evaluated by prediction tools,
s of potential novel miRNAs having high frequency or read count.
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same as the reference miRNA sequence (submitted to
miRBase). This could be due to various reasons, such as
tissue specific expression of a specific isomiR or variable
degradation rates of different isomiRs. Overall the results
presented here suggest that strand selection and pro-
cessing of miRNAs are likely to be regulated and may be
related to phenotypic differences of tissues and cells.
This dynamic nature of isomiRs and their tendency of
changing with different conditions can affect any ana-
lysis that relies on miRNA expression profile. The Refer-
ence miRNA expression profile may not provide an
exact representation of the miRNA transcriptome. As
our results showed that the Reference miRNA expres-
sion profile missed out nearly 255 miRNAs and also
identified a fewer number of highly expressed miRNAs,
this could lead to incomplete and sometimes a mislead-
ing analysis. The Abundant isomiR profile can provide a
more appropriate and clearer picture of the miRNA
transcriptome and should be used for further down-
stream analysis such as differential expression estimation
and even for finding commonly expressed miRNAs
among samples.
Our results on identification of novel miRNAs from
sRNA sequences suggest that there are still many novel
miRNAs that have not yet been identified. Therefore it is
important to find these novel miRNAs in order to define
the miRNA transcriptome.
In summary NGS based analysis of sRNA sequences
allows complete deciphering of miRNA transcriptome
that includes all the isoforms. We are still not clear
about the mechanism by which a given cell or tissue de-
cides the functional isoform of a given miRNA and regu-
lation of isoform switching.
Methods
Cell line and blood samples preparation
Buffy coat of healthy blood donors (Normal1 and
Normal2) were collected from volunteers. Red cell lysis
buffer (0.144 M NH4Cl, 0.01 M NH4HCO3) was added
to buffy coat to lyse the remnant RBCs and pure WBC
population was obtained by centrifugation at 3000 g.
Peripheral blood mononuclear cells were obtained at
diagnosis from patients with CML after signed informed
consent had been obtained from the patient in accord-
ance with the Declaration of Helsinki. This study was
approved by the hospital (AIIMS, New Delhi) according
to the guidelines of the hospital’s ethics committee
(Reference no. A-36:20/10/04).
RNA isolation and sequencing
Total RNA isolation was carried out from peripheral
blood using TRIzol® Reagent (Invitrogen) as per manu-
facturer’s instruction. RNA preparations were storedat − 80°C till further use. Small RNA population was iso-
lated by separating 10 μg of total RNA on denaturing
polyacrylamide gel electrophoresis (PAGE) and cutting a
portion of the gel corresponding to the size 18–30
nucleotides based standard oligonucleotide markers.
Adapter (5′) was ligated to sRNA population and ligated
RNAs (40–60 nt) were purified by running on urea
PAGE. This was followed by 3′ adapter ligation and
purification of adapter ligated RNAs (70–90 nt) in a
similar manner. Modified sRNAs were reverse tran-
scribed and then PCR amplified with adapter specific
primers and the amplified cDNAs were finally purified
on Urea PAGE to generate cDNA tag libraries for se-
quencing by illumina genome analyzer.
Data sets information
The sRNA sequencing data containing PBMC of two
normal individuals (Normal1, Normal2) and two CML
patients (Patient1, Patient2) were obtained from Illumina
high throughput sequencing platform. The sequences
shorter than the cut-off read length (14nt), as deter-
mined by the read length distribution plot (Figure 1),
were removed from all the four samples. The total num-
ber of reads for all the samples before and after the ap-
plication of the read length cut-off is mentioned in
Table 1.
Annotation and data classification
The sRNA sequences obtained were annotated against
the known databases using the Elimination pipeline as
used in our previous work [24,30]. The Elimination
module was used for fast matching of the sequences
with the databases. A mismatch of up to 2 nucleotides
was allowed. The pool of unannotated sequences at the
end of the pipeline served as a source of potential novel
miRNAs.
Reference miRNA expression profile generation
To generate the expression profile of the reference
miRNAs, the sRNA sequences of all the samples were
matched against the known mature miRNA sequences
in miRBase using BLASTN. The parameters used for
BLAST were tuned to obtain maximum matches, such
as the word size was set to 7 nucleotides, filtering was
turned off and the number of alignments reported were
increased. The profile comprises of a list of the “refer-
ence” miRNAs along with their frequency or expression
value for all the 4 samples (Additional file 1).
Alignment of the reads and isomiR identification
As mentioned in the introduction section, isomiRs are
variant forms of the miRNAs caused by alternative Dicer
cutting [23]. To obtain the isomiRs for every known
miRNA, an alignment of the reads to the pre-miRNA
Vaz et al. BMC Research Notes 2013, 6:390 Page 10 of 12
http://www.biomedcentral.com/1756-0500/6/390hairpins is necessary. This alignment facilitates identifi-
cation of isomiRs of mature miRNA sequences derived
from both, the 5′ and the 3′ region of the pre-miRNA
hairpin.
Alignment of the reads to the pre-miRNAs
The alignment was done by the Bowtie software using
the default parameters [38]. The pre-miRNAs were
downloaded from miRBase Release 19 comprising of
1600 pre-miRNAs and 2042 mature miRNA sequences
[26]. Reads from each of the four samples were aligned
to the reference pre-miRNAs. The output was an align-
ment of the deep sequencing reads to the Homo sapiens
reference pre-miRNAs.
Obtaining clusters of the isomiRs
The alignment output was processed by a perl script de-
veloped specifically to get a cluster of isomiRs that are
actually reads that match at the same location but differ
by a few nucleotides at the 5′ and 3′ ends. Such clusters
were obtained for every miRNA from both the regions
(5′ and 3′ region) of the hairpin using the position infor-
mation given in the output of the alignment. To demon-
strate this, the isomiR family of hsa-let-7b is shown in
Additional file 2.
Abundant isomiR expression profile generation
The isomiR clusters generated as mentioned earlier were
analyzed to obtain the most abundant member. An
abundant isomiR expression profile comprising of a list
of the known miRNAs along with the frequency of the
“most abundant isomiR” for all the samples was then
created (Additional file 3).
Comparison of the reference miRNA profile and the
abundant isomiR expression profile
The most abundant member could either be the refer-
ence miRNA or some other isomiR. Cases where the
most abundant isomiR was the reference miRNA itself,
was denoted by “YES”, whereas the cases where another
isomiR was the abundant one was denoted by “NO”
(Additional file 4).
Novel miRNA prediction
After the NGS datasets were passed through the elimin-
ation pipeline to sieve out all the known RNAs, the
unannotated ones were matched with the intergenic and
intronic regions of the genome to obtain exact matched
sequences. Since the intergenic and intronic regions are
known to be sources of the miRNA genes, the
unannotated RNA sequences were matched for identify-
ing potential novel miRNAs sequences. The exact
matches were extended in length corresponding to the
average length of a precursor miRNA and then subjectedto the ab-initio miRNA prediction algorithms such as
the SCFG based CID-miRNA [31] and CSHMM [32]
that can predict miRNAs with high sensitivity and
specificity.
The ones predicted as miRNAs by these prediction
algorithms were further checked for the following
features of a miRNA that serve as filters:
1. Presence of the concerned sRNA in one of the arms
of the stem region (−5p or−3p) of the hairpin.
2. Presence of one or more isomiR of that sRNA.
3. Presence of another sRNA in the other arm of the
stem region (−5p or−3p) of the hairpin.
Following is the detailed pipeline for predicting potential
novel miRNAs (Vaz et al., 2010) [24,30]:
i. Matching and Extending
The unannotated sRNAs which had frequencies
above or equal to 5 were matched to the intergenic/
intronic regions. The exact matched sequences were
extracted along with 70 nucleotides flanking both
the ends to obtain sequences of length comparable
to a precursor miRNA sequence.
ii. Folding and Filtering
The extended sequences were tested by CID-miRNA
[31] and CSHMM [32] prediction tools to find for
potential pre-miRNAs. The potential pre-miRNAs
reported by these tools were then checked to see if
the concerned sRNA occurred in the folded putative
precursor and was located in one of the arms of the
stem region. Since mature miRNAs are known to be
arising from the stem portion and not the loop, only
those hairpins in which the sRNAs occurred in the
stem were classified as correct cases and the
remaining as prediction errors. These correct cases
were further tested by MiPred [34].
iii. Identifying isomiRs and counterparts
The sRNAs derived from common precursors
that were predicted as correct cases, were
grouped into a family. The most abundant
member of a family was designated as the major
mature miRNA. The sRNAs that differed from
the representative by a few nucleotides were
called its isomiRs and those that had a different,
partially complementary sequence and were
located in the other strand (stem of the hairpin
loop) were treated as its putative counterparts.
The Additional file 5 comprise of the potential
novel miRNAs grouped into families on the
basis of sRNAs falling within the same
precursor. The scores from the 4 tools (CID-
miRNA, CSHMM, miRDeep, MiPred) assigned
to the corresponding precursors are also listed.
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Finally, the novel miRNA candidates from all the
samples were pooled and the redundancy was
removed to get a final set of potential novel
miRNAs. These were given a unique name and were
listed along with their sample IDs. The Additional
file 5 comprises the details of all the mature and
precursor potential novel miRNAs. The sequence
and the structures of two potential novel miRNAs is
shown in Figure 6. The Additional file 6 comprises
of the structures of all the potential novel
precursors.
Availability of supporting data
The raw data sets supporting the results of this article
are available in the Sequence Read Archive (SRA)
repository. BioProject ID: PRJNA216976.
BioSample accessions: SAMN02333778, SAMN02333
779, SAMN02333780, SAMN02333781.
Additional files
Additional file 1: Reference miRNA Expression Profile. A list of the
reference miRNAs, with their raw frequency or expression values as well
as the normalized expression values through TPM for all the four
samples. TPM (transcripts parts per million) = miRNA Frequency / Total
number of reads in the sample * 106.
Additional file 2: An example of a Standard isomiR expression
profile. A list of all the let-7b isomiRs for each sample with position and
strand information.
Additional file 3: Abundant isomiR Expression Profile. A list of the
most abundant isomiR, with their raw frequency or expression values as
well as the normalized expression values through TPM for all the four
samples.
Additional file 4: Classification of the abundant isomiRs as the
reference miRNA or not. Cases where the most abundant isomiR was
the reference miRNA itself, was denoted by “YES”, whereas the cases
where another isomiR was the most abundant one was denoted
by “NO”.
Additional file 5: Details of the potential novel miRNAs. A list of the
potential novel miRNAs predicted sample wise, with the information on
their frequency, isomiRs and prediction scores from CID-miRNA, CSHMM,
miRDeep, MiPred (Sheet 1). The precursor and mature sequences of the
total potential novel miRNAs are given as text file (Sheet 2). All these 17
potential novel miRNAs names have a prefix: “jnu-pat-hsa” and are
numbered from 1 to 17.
Additional file 6: Structures of the potential novel miRNAs.
Structures of all the 17 potential novel miRNAs from CID-miRNA
prediction tool.
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